170 related articles for article (PubMed ID: 24671359)
1. Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients.
Lee HS; Ko BS; Ahn SH; Son BH; Lee JW; Kim HJ; Yu JH; Kim SB; Jung KH; Ahn JH; Cha JH; Kim HH; Lee HJ; Song IH; Gong G; Park SH; Lee JJ; Moon DH
Breast Cancer Res Treat; 2014 May; 145(1):91-100. PubMed ID: 24671359
[TBL] [Abstract][Full Text] [Related]
2. Breast-Specific Gamma Imaging Versus MRI: Comparing the Diagnostic Performance in Assessing Treatment Response After Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Kim S; Plemmons J; Hoang K; Chaudhuri D; Kelley A; Cunningham T; Hoefer R
AJR Am J Roentgenol; 2019 Mar; 212(3):696-705. PubMed ID: 30620672
[TBL] [Abstract][Full Text] [Related]
3. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J
BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536
[TBL] [Abstract][Full Text] [Related]
4. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
6. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.
Keto JL; Kirstein L; Sanchez DP; Fulop T; McPartland L; Cohen I; Boolbol SK
Ann Surg Oncol; 2012 Jan; 19(1):249-52. PubMed ID: 21739318
[TBL] [Abstract][Full Text] [Related]
7. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
Brem RF; Fishman M; Rapelyea JA
Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI.
Kim BS
Ann Nucl Med; 2012 Feb; 26(2):131-7. PubMed ID: 22006539
[TBL] [Abstract][Full Text] [Related]
9. Comparison of BSGI and MRI as Approaches to Evaluating Residual Tumor Status after Neoadjuvant Chemotherapy in Chinese Women with Breast Cancer.
Liu H; Zhan H; Zhang Y; He G; Wang H; Zhang Q; Zheng L
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679544
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
11. Breast-specific gamma camera imaging with
Zhang A; Li P; Liu Q; Song S
Hell J Nucl Med; 2017; 20(1):26-35. PubMed ID: 28315905
[TBL] [Abstract][Full Text] [Related]
12. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
Johnson N; Sorenson L; Bennetts L; Winter K; Bryn S; Johnson W; Glissmeyer M; Garreau J; Blanchard D
Am J Surg; 2014 May; 207(5):698-701; discussion 701. PubMed ID: 24791629
[TBL] [Abstract][Full Text] [Related]
13. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
Park S; Yoon JH; Sohn J; Park HS; Moon HJ; Kim MJ; Kim EK; Kim SI; Park BW
PLoS One; 2016; 11(2):e0149347. PubMed ID: 26866475
[TBL] [Abstract][Full Text] [Related]
15. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Hunt KN; Conners AL; Goetz MP; O'Connor MK; Suman V; Kalari K; Weinshilboum R; Wang L; Carter J; McLaughlin S; Aspitia AM; Gray R; Northfelt D; Boughey JC
AJR Am J Roentgenol; 2019 Oct; 213(4):932-943. PubMed ID: 31166752
[No Abstract] [Full Text] [Related]
17. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
18. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient.
Zhou M; Johnson N; Gruner S; Ecklund GW; Meunier P; Bryn S; Glissmeyer M; Steinbock K
Am J Surg; 2009 Feb; 197(2):159-63. PubMed ID: 19185109
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy.
Moon HG; Han W; Ahn SK; Cho N; Moon WK; Im SA; Park IA; Noh DY
Ann Surg; 2013 Jan; 257(1):133-7. PubMed ID: 22968080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
